These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 10706934)

  • 1. On the mechanism of the spermine-exerted inhibition on alpha-thrombin-induced platelet activation.
    Via LD; Francesconi M; Mazzucato M; Pradella P; De Marco L; Vecchia FD; Rascio N; Deana R
    Thromb Res; 2000 Apr; 98(1):59-71. PubMed ID: 10706934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human platelet activation is inhibited by the occupancy of glycoprotein IIb/IIIa receptor.
    Padoin E; Alexandre A; Cavallini L; Polverino de Laureto P; Rao GH; Doni MG
    Arch Biochem Biophys; 1996 Sep; 333(2):407-13. PubMed ID: 8809080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polyamines inhibit both platelet aggregation and glycoprotein IIb/IIIa activation.
    Corona-de-la-Peña N; Uribe-Carvajal S; Barrientos-Rios R; Matias-Aguilar L; Montiel-Manzano G; Majluf-Cruz A
    J Cardiovasc Pharmacol; 2005 Aug; 46(2):216-21. PubMed ID: 16044034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Difference of (Ca2+)i movements in platelets stimulated by thrombin and TRAP: the involvement of alpha(IIb)beta3-mediated TXA2 synthesis.
    Aoki T; Tomiyama Y; Honda S; Senzaki K; Tanaka A; Okubo M; Takahashi F; Takasugi H; Seki J
    Thromb Haemost; 1998 Jun; 79(6):1184-90. PubMed ID: 9657446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incomplete inhibition of platelet aggregation and glycoprotein IIb-IIIa receptor blockade by abciximab: importance of internal pool of glycoprotein IIb-IIIa receptors.
    Gawaz M; Ruf A; Pogatsa-Murray G; Dickfeld T; Rüdiger S; Taubitz W; Fischer J; Müller I; Meier D; Patscheke H; Schömig A
    Thromb Haemost; 2000 Jun; 83(6):915-22. PubMed ID: 10896249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High molecular weight kininogen inhibits thrombin-induced platelet aggregation and cleavage of aggregin by inhibiting binding of thrombin to platelets.
    Puri RN; Zhou F; Hu CJ; Colman RF; Colman RW
    Blood; 1991 Feb; 77(3):500-7. PubMed ID: 1846761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The in-vitro effect of tirofiban, glycoprotein IIb/IIIa antagonist, on various responses of porcine blood platelets.
    Ciborowski M; Tomasiak M; Rusak T; Winnicka K; Dobrzycki S
    Blood Coagul Fibrinolysis; 2008 Sep; 19(6):557-67. PubMed ID: 18685439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of the polyamine-spermine on agonist-induced human platelet activation--specific inhibition of "aggregation-independent" events induced by thrombin, but not by collagen, thromboxane mimetic, phorbol ester or calcium ionophore.
    Joseph S; Krishnamurthi S; Kakkar VV
    Thromb Haemost; 1987 Apr; 57(2):191-5. PubMed ID: 3110996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antagonism of the GPIIb/IIIa receptor with the nonpeptidic molecule BIBU52: inhibition of platelet aggregation in vitro and antithrombotic efficacy in vivo.
    Guth BD; Seewaldt-Becker E; Himmelsbach F; Weisenberger H; Müller TH
    J Cardiovasc Pharmacol; 1997 Aug; 30(2):261-72. PubMed ID: 9269956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The in vitro effect of eptifibatide, a glycoprotein IIb/IIIa antagonist, on various responses of porcine blood platelets.
    Ciborowski M; Tomasiak M
    Acta Pol Pharm; 2009; 66(3):235-42. PubMed ID: 19645323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiplatelet activity of green tea catechins is mediated by inhibition of cytoplasmic calcium increase.
    Kang WS; Chung KH; Chung JH; Lee JY; Park JB; Zhang YH; Yoo HS; Yun YP
    J Cardiovasc Pharmacol; 2001 Dec; 38(6):875-84. PubMed ID: 11707691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A peptide ligand of the human thrombin receptor antagonizes alpha-thrombin and partially activates platelets.
    Rasmussen UB; Gachet C; Schlesinger Y; Hanau D; Ohlmann P; Van Obberghen-Schilling E; Pouysségur J; Cazenave JP; Pavirani A
    J Biol Chem; 1993 Jul; 268(19):14322-8. PubMed ID: 8390990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. YD-3, a novel inhibitor of protease-induced platelet activation.
    Wu CC; Huang SW; Hwang TL; Kuo SC; Lee FY; Teng CM
    Br J Pharmacol; 2000 Jul; 130(6):1289-96. PubMed ID: 10903968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative study of antiplatelet drugs in vitro: distinct effects of cAMP-elevating drugs and GPIIb/IIIa antagonists on thrombin-induced platelet responses.
    Matsumoto Y; Marukawa K; Okumura H; Adachi T; Tani T; Kimura Y
    Thromb Res; 1999 Jul; 95(1):19-29. PubMed ID: 10403683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Halysin, an antiplatelet Arg-Gly-Asp-containing snake venom peptide, as fibrinogen receptor antagonist.
    Huang TF; Liu CZ; Ouyang CH; Teng CM
    Biochem Pharmacol; 1991 Aug; 42(6):1209-19. PubMed ID: 1888330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of action of the antiplatelet peptide, arietin, from Bitis arietans venom.
    Huang TF; Wang WJ; Teng CM; Ouyang C
    Biochim Biophys Acta; 1991 May; 1074(1):144-50. PubMed ID: 2043664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the calmodulin antagonists fendiline and calmidazolium on aggregation, secretion of ATP, and internal calcium in washed human platelets.
    Lückhoff A; Bohnert M; Busse R
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Jan; 343(1):96-101. PubMed ID: 2030746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The fibrinogen gamma chain dodecapeptide inhibits agonist-induced aggregation of rabbit platelets and fibrinogen binding to rabbit glycoprotein IIb-IIIa.
    Rand ML; Packham MA; Taylor DM; Yeo EL; Gemmell CH; Patil S; Lam SC
    Thromb Haemost; 1999 Dec; 82(6):1680-6. PubMed ID: 10613655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiplatelet mechanism of 2-chloro-3-(4-hexylphenyl)-amino-1,4-naphthoquinone (NQ304), an antithrombotic agent.
    Zhang YH; Chung KH; Ryu CK; Lee YH; Kim TJ; Song YS; Hwang KA; Yun YP
    Pharmacol Toxicol; 2001 Apr; 88(4):181-6. PubMed ID: 11322175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of a new platelet glycoprotein IIb/IIIa antagonist, SR121566, on platelet activation, platelet-leukocyte interaction and thrombin generation.
    Li N; Wallén NH; Savi P; Hérault JP; Herbert JM
    Blood Coagul Fibrinolysis; 1998 Sep; 9(6):507-15. PubMed ID: 9819001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.